関東化学株式会社 List of Products and Services

【New Coronavirus S Gene Mutation Detection Real-time PCR Kit】 The "PowerChek SARS-CoV-2 S-gene Mutation Detection Kit series" is a product that allows for the simultaneous screening of multiple mutations in the S protein of the novel coronavirus from RNA extracts. Positive controls and internal controls are included. 【New Product: PowerChek SARS-CoV-2 S-gene Mutation Detection Kit Ver.3.0】 We are now launching a product that enables the simultaneous screening of seven mutations in the S protein, including those possessed by the Omicron variant (K417N, L452R, E484A/K, N501Y, T547K, P681R). ★ Compatible Models ■ BioRad / CFX96 System ■ ThermoFisher / Applied Biosystems 7500, 7500 Fast, QuantStudio 5 ★ This kit is for research and testing use only. It has not received approval or certification as an in vitro diagnostic medical device.

KogeneBiotech, established in 2000, is the top manufacturer of gene detection kits in South Korea and currently manufactures and sells over 500 items of real-time PCR and conventional PCR kits. In February 2020, KogeneBiotech received the first approval in South Korea for the "PowerChek 2019-nCoV Real-time PCR Kit" as an in vitro diagnostic medical device (IVD), and since then, it has developed and sold various real-time PCR reagents related to the novel coronavirus (SARS-CoV-2). Each kit includes all the necessary reagents for measurement, such as enzymes and positive controls, enabling rapid and accurate detection of the novel coronavirus genes. ★ This kit series is for research and testing purposes only. It has not received approval or certification as an in vitro diagnostic medical device.

● Easy operation allows for the purification of high-purity nucleic acids (DNA/RNA) in about 20 minutes. ● Can be used for samples in various applications such as PCR.

This is a mouse monoclonal antibody that can specifically detect the SARS-CoV-2 antigen. It was developed in collaboration with Professor Akihide Ryo of the Graduate School of Medicine at Yokohama City University. It has been validated for use in antigen detection methods such as sandwich ELISA and lateral flow immunoassays. Since it is purified and produced from the culture supernatant of hybridomas using serum-free media, it is a high-purity antibody with minimal lot-to-lot variation. 【Features】 ● High specificity and affinity It does not cross-react with SARS-CoV, MERS-CoV, or other common human coronaviruses that cause colds, showing high affinity exclusively for SARS-CoV-2. ● Usable for antigen detection methods It has been validated that sandwich ELISA and lateral flow immunoassays can be constructed by combining various antibodies. ● Epitopes of the antibodies have been identified * The epitopes of each antibody will be disclosed after the conclusion of a Material Transfer Agreement (MTA).

The "SARS-CoV-2 Gene Testing Accuracy Control" is a product for quality control of gene detection and antigen testing for SARS-related coronaviruses. Following the outbreak of SARS-CoV-2, which was first reported in 2019, gene testing to detect SARS-CoV-2 has been conducted worldwide. Our company offers a variety of accuracy control products for gene testing of SARS-CoV-2, including some variants from Microbiologics (USA). 【Product Lineup】 ■ For accuracy control from RNA extraction to gene detection 　－ Inactivated viruses: 6 types 　－ Negative controls: 2 types ■ For accuracy control of gene detection 　－ Positive controls for PCR: 2 types ■ For accuracy control of antigen testing 　－ Antigen test control: 1 type For more details, please download the catalog or feel free to contact us.